Lu S - Search Results

1

Nedaplatin Plus Docetaxel Versus Cisplatin Plus Docetaxel as First-Line Chemotherapy for Advanced Squamous Cell Carcinoma of the Lung - A Multicenter, Open-label, Randomized, Phase III Trial.

Lu S, Chen Z, Hu C, Zhang J, Chen Y, Song Y, Zhao Q, Fan Y, Wu G, Ma Z, Fang J, Yu Q, Liu Z. Lu S, et al. J Thorac Oncol. 2018 Nov;13(11):1743-1749. doi: 10.1016/j.jtho.2018.07.006. Epub 2018 Jul 11. J Thorac Oncol. 2018. PMID: 30017831 Free article. Clinical Trial.

2

[Incidence, time trend, survival, and predictive factors of lung cancer in Shanghai populations].

Liao ML, Chen ZW, Zheng Y, Wu CX, Lu S, Yu YF, Jian H, Cheng BJ. Liao ML, et al. Among authors: lu s. Zhonghua Yi Xue Za Zhi. 2007 Jul 17;87(27):1876-80. Zhonghua Yi Xue Za Zhi. 2007. PMID: 17923007 Chinese.

3

[Evaluation of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in lung cancer patients].

Xu YH, Chen ZW, Ye XY, Lu S. Xu YH, et al. Among authors: lu s. Zhonghua Zhong Liu Za Zhi. 2008 Sep;30(9):716-9. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 19173920 Clinical Trial. Chinese.

4

Predictive significance of bone sialoprotein and osteopontin for bone metastases in resected Chinese non-small-cell lung cancer patients: a large cohort retrospective study.

Zhang L, Hou X, Lu S, Rao H, Hou J, Luo R, Huang H, Zhao H, Jian H, Chen Z, Liao M, Wang X. Zhang L, et al. Among authors: lu s. Lung Cancer. 2010 Jan;67(1):114-9. doi: 10.1016/j.lungcan.2009.03.017. Lung Cancer. 2010. PMID: 19376608

5

Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China.

Li Z, Yu Y, Lu J, Luo Q, Wu C, Liao M, Zheng Y, Ai X, Gu L, Lu S. Li Z, et al. Among authors: lu j, lu s. J Thorac Oncol. 2009 Jun;4(6):702-9. doi: 10.1097/JTO.0b013e3181a5269d. J Thorac Oncol. 2009. PMID: 19404215 Free article.

6

[Comparison of single-agent docetaxel versus docetaxel plus platinum combination agent in second-line treatment for advanced non-small cell lung cancer].

Zhang YF, Yu YF, Lu S. Zhang YF, et al. Among authors: lu s. Zhonghua Yi Xue Za Zhi. 2009 Jun 9;89(22):1544-8. Zhonghua Yi Xue Za Zhi. 2009. PMID: 19953882 Chinese.

7

Pemetrexed monotherapy versus pemetrexed plus platinum combination as second-line treatment for advanced non-small cell lung cancer.

Zhang YF, Chen ZW, Lu S. Zhang YF, et al. Among authors: lu s. Chin Med J (Engl). 2009 Oct 20;122(20):2472-6. Chin Med J (Engl). 2009. PMID: 20079162

8

Association of the CHRNA3 locus with lung cancer risk and prognosis in Chinese Han population.

Niu X, Chen Z, Shen S, Liu Y, Zhou D, Zhang J, Li Z, Yu Y, Liao M, Lu S, He L. Niu X, et al. Among authors: lu s. J Thorac Oncol. 2010 May;5(5):658-66. doi: 10.1097/JTO.0b013e3181d5e447. J Thorac Oncol. 2010. PMID: 20234319 Free article.

9

Functional roles of PC-PLC and Cdc20 in the cell cycle, proliferation, and apoptosis.

Chen Z, Yu Y, Fu D, Li Z, Niu X, Liao M, Lu S. Chen Z, et al. Among authors: lu s. Cell Biochem Funct. 2010 Jun;28(4):249-57. doi: 10.1002/cbf.1634. Cell Biochem Funct. 2010. PMID: 20517887

10

[Safety analysis of ambulatory chemotherapy in lung cancer].

Feng Y, Lu S, Song Z, Xu L, Shi Y, Chen Z. Feng Y, et al. Among authors: lu s. Zhongguo Fei Ai Za Zhi. 2010 Jul;13(7):713-6. doi: 10.3779/j.issn.1009-3419.2010.07.10. Zhongguo Fei Ai Za Zhi. 2010. PMID: 20673488 Free PMC article. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,212 results

Search Page

Filters